Innovation

A Novel Category of Bioactive Diiminopiperazines

Emory University
posted on 07/07/2009

Applications

These methods and compositions will be useful in controlling the biological processes affected by sphingolipids and for the treatment of disease that have disorders involving cell regulatory pathways.

Technical Summary

Sphingolipids are a group of lipids found in all eukaryotic cells, as well as some prokaryotes and viruses. The structural backbone of the sphingolipids are sphingosine and other long-chain (sphingoid) bases and have been found to affect diverse cellular systems including, protein kinase C, Na+, K+-ATPase, phosphatidic acid phosphatase, phospholipases (including phospholipase D), retinoblastoma protein phosphorylation, and sphingosine-activated protein kinases. Free sphingoid bases (sphinganine and spingosine), sphingosine-1-phosphate, and ceramides are formed endogenously as lipid mediators. Sphingolipids have been studied as intracellular lipid messengers for agonists such as tumor necrosis factor, nerve growth factor, platelet-derived growth factor, cytotoxic agents, and are involved in various forms of stress. Sphingolipid metabolites are highly active and control important cell functions, which include inflammation, growth, cell differentiation and development, cell death, and aging. Based on the involvement of sphingolipids in cellular systems, there is a need for methods or compositions that allow for control or modulation of sphingolipid metabolism. These methods and compositions will be useful in controlling the biological processes affected by sphingolipids and for the treatment of diseases that have disorders involving cell regulatory pathways. In addition, other bioactive lipid metabolites (such as diacylglycerols) have been shown to change during a transient sphingosine "burst," suggesting that agents that affect one cell signaling pathway may have important effects on other cell signaling systems and have a broad pharmacologic utility. These compounds also have the ability to modulate cell behavior in applications such as production of biomolecules using cells in culture and other types of bioreactors.

]]>


Innovation Details
 

File Number: 99060 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Cory Acuff at Emory University for more information.

Request more info via email request more info
People

Principal Investigator:

Alfred Merrill Alfred Merrill

Innovations (2)

Publications (3)



Co-Investigators:

Dennis Liotta Dennis Liotta

Innovations (11)

Lisa Warden Lisa Warden

Innovations (1)

Case Manager:

Cory Acuff Cory Acuff

Innovations (70)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,828 members 17,080 innovations 152 organizations

Browse

Patrick Jones, Ph.D. Director, Technology Transfer - University of Arizona

"The iBridge Network nicely embodies the ideals of a well-designed, non-profit mechanism for aggregating, searching, and disseminating innovations from multiple research institutions."  read more...